Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2026-06-09 18:43:22 ET · period of report 2026-06-05 · accession 0001610717-26-000205 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 18:43 | 2026-06-05 | CHRS | Karachun Rita A | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2026-06-09 18:43 | 2026-06-05 | CHRS | Karachun Rita A | Dir | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | A | A | 30,000 | $0.00 | 30,000 | D | — | — | (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-06-05 | A | A | 60,000 | $0.00 | 60,000 | D | $1.45 · — to 2036-06-05 | 60,000 Common Stock | (F2) The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. |